Hans D Brightbill
4PUBLICATIONS
76CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 07, 2026
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis.Rojo A Ratsimandresy, Emma Doran, Hart S Dengler
|May 26, 2023
LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung.Hsiao-Yen Ma, Qingling Li, Weng Ruh Wong
|Aug 05, 2021
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis.Tianhe Sun, Zhiyu Huang, Wei-Ching Liang
|Jun 04, 2020
The kinase IRAK4 promotes endosomal TLR and immune complex signaling in B cells and plasmacytoid dendritic cells.Cesar A Corzo, Eugene Varfolomeev, A Francesca Setiadi
Pageof 1
Frequent Collaborators
3 joint publications
Patrick Caplazi
3 joint publications
Merone Roose-Girma
2 joint publications
Daryle J DePianto
2 joint publications
Jason A Vander Heiden
2 joint publications
Tianhe Sun
2 joint publications
Claire Emson
2 joint publications
Lucinda Tam
2 joint publications
Katrina B Morshead
2 joint publications
Nico Ghilardi
2 joint publications
Cary D Austin
